StockClub

CTXR

CTXRCitius Pharmaceuticals, Inc.$ --
Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2026 Q1
Revenue
4M USD
YoY +Infinity%
Operating Income
-9M USD
YoY +10.2%
Net Income
-8M USD
YoY +15.8%
EPS
-0.38$
YoY +70.8%

Revenue

$3.9M
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$155,926
$155,926
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$3.9M
$3.9M
Q1
Actual
+$3.9M (-)

Net Income

$-8.2M
FY2024 Q2$-17.8M
$-17.8M
Q2
FY2024 Q3$-28.3M
$-28.3M
Q3
FY2024 Q4$-39.1M
$-39.1M
Q4
FY2025 Q1$-9.8M
$-9.8M
Q1
FY2025 Q2$-20.7M
$-20.7M
Q2
FY2025 Q3$-29.5M
$-29.5M
Q3
FY2025 Q4$-37.4M
$-37.4M
Q4
FY2026 Q1$-8.2M
$-8.2M
Q1
Actual
+$1.5M (+15.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022MISS
Actual:$0
Est:$103.2M
FY2022MISS
$0
FY2023
Actual:$0
FY2023
$0
FY2024MISS
Actual:$0
Est:$61.7M
FY2024MISS
$0
FY2025MISS
Actual:$0
Est:$7.7M
FY2025MISS
$0

Analyst Estimates